BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ATRASENTAN IN PATIENTS WITH IGAN
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/e56c803abf913e316ec7b2d5eafe6b4d.pdf
Abstract Title
BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ATRASENTAN IN PATIENTS WITH IGAN
First Name *
Hiddo J. L.
Last Name *
Heerspink
Co-author 1
Meg Jardine meg.jardine@sydney.edu.au University of Sydney NHMRC Clinical Trials Centre Sydney
Co-author 2
Donald E. Kohan donald.kohan@hsc.utah.edu University of Utah Health Sciences Center Division of Nephrology Salt Lake City
Co-author 3
Richard A. Lafayette czar@stanford.edu Stanford University Stanford Glomerular Disease Center Stanford
Co-author 4
Adeera Levin ALevin@providencehealth.bc.ca The University of British Columbia Division of Nephrology Vancouver
Co-author 5
Adrian Liew draliew2@gmail.com Mount Elizabeth Novena Hospital Renal Medicine Singapore
Co-author 6
Hong Zhang hongzh@bjmu.edu.cn Peking University First Hospital Renal Division Beijing
Co-author 7
Todd Gray tgray@chinooktx.com Chinook Therapeutics, a Novartis Company Biostatistics Seattle
Co-author 8
Khushboo Sheth ksheth@chinooktx.com Chinook Therapeutics, a Novartis Company Clinical Development Seattle
Co-author 9
Marianne Camargo mcamargo@chinooktx.com Chinook Therapeutics, A Novartis Company Clinical Development Seattle
Co-author 10
Ronny Renfurm ronny.renfurm@novartis.com Novartis Pharma AG Cardio-Renal Metabolism Global Drug Development Basel
Co-author 11
Andrew King aking@chinooktx.com Chinook Therapeutics, A Novartis Company Research and Development Seattle
Co-author 12
Jonathan Barratt jb81@leicester.ac.uk University Hospitals of Leicester NHS Trust Department of Cardiovascular Sciences, Renal Medicine Leicester
Co-author 13
Co-author 14
Co-author 15
E-Poster Format Requirements
PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but
must be saved and submitted as PDF file
.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos